Virtus Biotech Clinical Trials ETF
Virtus Biotech Clinical Trials ETF (BBC) Covered Calls
Read more
Running BBC covered calls helps you generate income from Virtus Biotech Clinical Trials ETF shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BBC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If BBC stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BBC covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BBC covered call is worth writing.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Loading covered call setups…
Stock Statistics
- IndustryExchange Traded Fund
- SectorFinancial
- IV Rank98.02% High
- Market cap (M$)—
- 52 weeks high-27.50%
- 52 weeks low41.82%
- Analyst recommendation—
- Target price—
- Dividend—
- Payout ratio—
- Earnings date—
- P/E—
- Future P/E—
- EPS (ttm)—
- EPS growth next 5 years—
As of Nov 5, 2026